Home » Archive by Category


La Jolla Pharmaceutical Company Announces Third Quarter And Year-To-Date 2014 Financial Results And Corporate Highlights

November 13, 2014 – 5:00 am | Edit Post

La Jolla Pharmaceutical Company (NASDAQ: LJPC) (the Company or La Jolla), a leader in the development of innovative therapies intended to significantly improve outcomes in patients suffering from life-threatening diseases, today reported third quarter and year-to-date 2014 financial results and highlighted recent corporate progress and near-term milestones. Help employers find you! Check…

Zogenix, Inc. To Participate In Healthcare Conference

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Zogenix, Inc. (Nasdaq:ZGNX), a pharmaceutical company developing and commercializing products for the treatment of pain-related conditions and central nervous system disorders, today announced that Zogenix management will present at the Stifel 2014 Healthcare…

Human Longevity Inc. Signs Collaborative Agreement With King’s College London To Access Twinsuk Registry

November 13, 2014 – 5:00 am | Edit Post

LA JOLLA, Calif., Nov. 13, 2014 /PRNewswire/ — Human Longevity, Inc. (HLI), a biological data-driven human health technology and cell therapy company, today announced a collaborative agreement with King’s College London to access their TwinsUK Registry.

DMI Diagnostic Device Wins Grand Prize In <b>Nokia</b> Sensing XPrize

November 13, 2014 – 5:00 am | Edit Post

The XPrize Foundation returned to San Diego today to announce that a team led by Eugene Y. Chan of the DNA Medicine Institute (DMI) in Cambridge, MA, is the winner of the second $525,000 grand prize in the Nokia Sensing XPrize Challenge. X Prize founder and chairman Peter Diamandis and Nokia CTO Henry Tirri announced the incentive prize competition during a 2012 digital health conference in San Diego…

Imprimis Pharmaceuticals Reports On Third Quarter 2014 Financial Results And Provides Update On Business Developments

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 /PRNewswire/ –Imprimis Pharmaceuticals, Inc. (NASDAQ: IMMY), a specialty pharmaceutical company focused on the development and commercialization of proprietary sterile and topical compounded drug formulations, today announced financial results for the third quarter ended

Conatus Pharmaceuticals Inc. Reports Third Quarter 2014 Financial Results And Program Updates

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 12, 2014 (GLOBE NEWSWIRE) — Conatus Pharmaceuticals Inc. (Nasdaq:CNAT), a biotechnology company focused on the development and commercialization of novel medicines to treat liver disease, today announced financial results for the quarter and nine months ended September 30, 2014, and…

Epic Sciences Appoints As Vice President Of Human Resources

November 13, 2014 – 5:00 am | Edit Post

SAN DIEGO, Nov. 13, 2014 /PRNewswire/ –Epic Sciences announced today the appointment ofToni Wayne as vice president of human resources. Ms. Wayne has more than 20 years of experience as a senior level human resources executive in diverse life sciences companies. At Epic, Ms. Wayne will develop best…

AstraZeneca PLC And Isis Pharmaceuticals, Inc. To Co-Develop Targeted Oligonucleotide Delivery Methods

November 13, 2014 – 5:00 am | Edit Post

CARLSBAD, Calif., Nov. 13, 2014 /PRNewswire/ –Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) and AstraZeneca today announced a strategic alliance to discover and develop novel delivery methods for antisense oligonucleotides. The new delivery approaches seek to target the desired tissue more effectively. The agreement…

Research Scientist – Indam Inc. – La Jolla, CA

November 13, 2014 – 2:37 am | Edit Post

Previous experience in pharma and/or biotech environment is preferred. He/she will design and execute experiments to evaluate, characterize and validate the…
From Indam Inc. – 13 Nov 2014 09:37:41 GMT
– View all La Jolla jobs

(Public Health / Epidemiology) PhD Researcher – Medical/ Biotechnology Background

November 12, 2014 – 10:00 pm | Edit Post

Details: ACON Laboratories, Inc. provides a broad range of high quality and competitively priced rapid diagnostic and healthcare products. ACON leads the way in making point of care medical diagnostics more affordable to people all around the world, and the ACON name is well known in over 130 countries. We will continue to expand our current rapid diagnostic and healthcare products worldwide. Indeed, we look forward to working with our partners and distributors to expand our current product lines, and to continue to provide products and services that allows us to meet and exceed the customers’ quality and price needs in all diverse markets throughout the world. Responsibilities: 1, track the development trend of international community health, analyze the direction of related areas in China; 2, study the innovative application of Chinese Community Health, integrate various application of new technologies to meet the huge demand of modern Community Health in China; 3, participate in the research and implementation of related topics organized by world’s top universities, take part in international communication and write papers; 4, design and implement the research projects independently,with good leadership.